Stock KRMD KORU MEDICAL SYSTEMS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus KORU Medical Systems, Inc.

Equities

KRMD

US7599101026

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
2.13 USD +0.95% Intraday chart for KORU Medical Systems, Inc. -3.18% -13.24%
May. 14 KORU Medical Systems Signs Supply Agreement for a Phase III Clinical Trial for a Novel Endocrinological Biologic CI
May. 01 Earnings Flash (KRMD) KORU MEDICAL SYSTEMS Posts Q1 Revenue $8.2M, vs. Street Est of $7.5M MT

Evolution of the average Target Price on KORU Medical Systems, Inc.

Price target over the last 5 years

History of analyst recommendation changes

702dfe7c67e3406882cf4.dG7a7kMrtuSKR9i5xPPTsjG639_uQOdeAh9QwtsT0qY.DBuevQtYhdH7MqHIo6yixgP1pZydd6BrRSoqsupc_9UwAKykKGbincUrrw~919c8f4a2b7c8046d54a748b2bbbbe09

Analyst Recommendations on KORU Medical Systems, Inc.

Lake Street Starts Repro Med Systems at Buy MT
B. Riley Starts Repro Med Systems at Buy With $4.50 Price Target, Says Risk/Reward Becoming More Favorable MT
Piper Sandler Adjusts Repro Med Systems Price Target to $4.50 From $3.50, Maintains Overweight Rating MT
Canaccord Genuity Upgrades Repro Med Systems to Buy Rating From Hold, Adjusts Price Target to $4 From $3 MT
Piper Sandler Upgrades Repro Med Systems to Overweight From Neutral, Adjusts Price Target to $3.50 From $3 MT
REPRO MED : Canaccord Genuity Downgrades Repro Med Systems to Hold From Buy; Price Target is $5 MT
REPRO MED : Piper Sandler Downgrades Repro Med Systems to Neutral From Overweight, Adjusts Price Target to $4.50 From $9 MT
REPRO MED : Canaccord Genuity Adjusts Repro Med Systems PT to $10 From $13, Maintains Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
2.13 USD
Average target price
3.5 USD
Spread / Average Target
+64.32%
High Price Target
4 USD
Spread / Highest target
+87.79%
Low Price Target
2.5 USD
Spread / Lowest Target
+17.37%

Consensus detail

Consensus revision (last 18 months)

Analysts covering KORU Medical Systems, Inc.

Lake Street
B. Riley
Piper Sandler
Canaccord Genuity

Ratings for KORU Medical Systems, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. KRMD Stock
  4. Consensus KORU Medical Systems, Inc.